Search Within

Elisa De Stanchina

  1. "Breast Medicine Service"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (16)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Breast Medicine Service (59)
  2. Department of Medicine (59)
  3. Solid Tumor Oncology Division (59)
  4. GSK Faculty (56)
  5. Sloan Kettering Institute Postdocs (49)
  6. Sloan Kettering Institute Faculty (43)

More Groups

People
  1. Neal Rosen (37)
  2. Sarat Chandarlapaty (20)
  3. Rona Yaeger (15)
  4. Michael Berger (12)
  5. Qing Chang (12)
  6. Zhan Yao (12)

More People

Years
  1. 2025 (4)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (7)

More Years

Publications
  1. Cancer Research (15)
  2. Cancer Discovery (9)
  3. Nature Communications (4)
  4. Cancer Cell (3)
  5. Clinical Cancer Research (3)
  6. Nature (3)

More Publications

Publishers
  1. American Association for Cancer Research (29)
  2. Nature Publishing Group (11)
  3. Cell Press (7)
  4. American Association for the Advancement of Science (2)
  5. Elsevier Inc. (2)
  6. National Academy of Sciences (2)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
    Journal Article

    Boyer, J. A.; Rosen, E. Y.; Sharma, M.; Dorso, M. A.; Mai, N.; Amor, C.; Reiter, J. M.; Kannan, R.; Gadal, S.; Xu, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations
    Journal Article

    Marasco, M.; Kumar, D.; Garcia Borrego, S.; Seale, T.; Maddalena, G.; Mezzadra, R.; Belanger, K.; Cole, S.; Perez, B.; Luan, W.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers
    Journal Article

    Cai, Y.; Zhao, P.; Wu, F.; Zhao, H.; Shao, H.; Marra, A.; Patel, P.; O’Connell, E.; Fink, E.; Miele, M. M.; more...
    Science Translational Medicine (2025)

    Fulltext@MSK | Save
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Tumor adaptation to PI3K inhibition and its stability increases as a function of time and is overcome by combined inhibiting Bcl2 family proteins
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Sharma, M.; Solomon, H.; De Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • EGFR-directed antibodies promote HER2 ADC internalization and efficacy
    Journal Article

    Gupta, A.; Michelini, F.; Shao, H.; Yeh, C.; Drago, J. Z.; Liu, D.; Rosiek, E.; Romin, Y.; Ghafourian, N.; Thyparambil, S.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Journal Article

    Roychowdhury, T.; McNutt, S. W.; Pasala, C.; Nguyen, H. T.; Thornton, D. T.; Sharma, S.; Botticelli, L.; Digwal, C. S.; Joshi, S.; Yang, N.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Combined inhibition of KRAS(G12C) and mTORC1 kinase is synergistic in non-small cell lung cancer
    Journal Article

    Kitai, H.; Choi, P. H.; Yang, Y. C.; Boyer, J. A.; Whaley, A.; Pancholi, P.; Thant, C.; Reiter, J.; Chen, K.; Markov, V.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • A druggable FOXA1-glucocorticoid receptor transcriptional axis drives tumor growth in a subset of non-small cell lung cancer
    Journal Article

    Dorso, M.; Patel, P. T.; Pankov, A.; Boyer, J. A.; Soni, R. K.; Del Priore, I. S.; Hayatt, O.; Kulick, A.; Hagen, C. J.; de Stanchina, E.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save